Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)

Salva R. Yurista; Herman H.W. Silljé; Kirsten T. Nijholt; Martin M. Dokter; Dirk J. van Veldhuisen; Rudolf A. de Boer; B. Daan Westenbrink

doi:10.1007/s10557-020-07029-2

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)

Salva R. Yurista, Herman H.W. Silljé, Kirsten T. Nijholt, Martin M. Dokter, Dirk J. van Veldhuisen, Rudolf A. de Boer, B. Daan Westenbrink^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

MI surgery increased the myocardial expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and increased the relative expression of foetal (β-MHC) compared to with that of adult (α-MHC) myosin heavy-chain isoform (i.e. β-MHC/α-MHC ratio).

Original language	English
Pages (from-to)	403
Number of pages	1
Journal	Cardiovascular Drugs and Therapy
Volume	35
Issue number	2
DOIs	https://doi.org/10.1007/s10557-020-07029-2
Publication status	Published - Apr 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Access to Document

10.1007/s10557-020-07029-2

Fingerprint

Dive into the research topics of 'Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)'. Together they form a unique fingerprint.

Cite this

Yurista, S. R., Silljé, H. H. W., Nijholt, K. T., Dokter, M. M., van Veldhuisen, D. J., de Boer, R. A., & Westenbrink, B. D. (2021). Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7). Cardiovascular Drugs and Therapy, 35(2), 403. https://doi.org/10.1007/s10557-020-07029-2

@article{e2d8e5d951554638909d9d59b155c8b4,

title = "Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)",

abstract = "MI surgery increased the myocardial expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and increased the relative expression of foetal (β-MHC) compared to with that of adult (α-MHC) myosin heavy-chain isoform (i.e. β-MHC/α-MHC ratio).",

author = "Yurista, {Salva R.} and Sillj{\'e}, {Herman H.W.} and Nijholt, {Kirsten T.} and Dokter, {Martin M.} and {van Veldhuisen}, {Dirk J.} and {de Boer}, {Rudolf A.} and Westenbrink, {B. Daan}",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2021",

month = apr,

doi = "10.1007/s10557-020-07029-2",

language = "English",

volume = "35",

pages = "403",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

number = "2",

}

Yurista, SR, Silljé, HHW, Nijholt, KT, Dokter, MM, van Veldhuisen, DJ, de Boer, RA & Westenbrink, BD 2021, 'Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)', Cardiovascular Drugs and Therapy, vol. 35, no. 2, pp. 403. https://doi.org/10.1007/s10557-020-07029-2

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7). / Yurista, Salva R.; Silljé, Herman H.W.; Nijholt, Kirsten T. et al.
In: Cardiovascular Drugs and Therapy, Vol. 35, No. 2, 04.2021, p. 403.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction to

T2 - Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)

AU - Yurista, Salva R.

AU - Silljé, Herman H.W.

AU - Nijholt, Kirsten T.

AU - Dokter, Martin M.

AU - van Veldhuisen, Dirk J.

AU - de Boer, Rudolf A.

AU - Westenbrink, B. Daan

PY - 2021/4

Y1 - 2021/4

N2 - MI surgery increased the myocardial expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and increased the relative expression of foetal (β-MHC) compared to with that of adult (α-MHC) myosin heavy-chain isoform (i.e. β-MHC/α-MHC ratio).

AB - MI surgery increased the myocardial expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) and increased the relative expression of foetal (β-MHC) compared to with that of adult (α-MHC) myosin heavy-chain isoform (i.e. β-MHC/α-MHC ratio).

UR - http://www.scopus.com/inward/record.url?scp=85087291040&partnerID=8YFLogxK

U2 - 10.1007/s10557-020-07029-2

DO - 10.1007/s10557-020-07029-2

M3 - Comment/Letter to the editor

C2 - 32613292

AN - SCOPUS:85087291040

SN - 0920-3206

VL - 35

SP - 403

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 2

ER -

Yurista SR, Silljé HHW, Nijholt KT, Dokter MM, van Veldhuisen DJ, de Boer RA et al. Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7). Cardiovascular Drugs and Therapy. 2021 Apr;35(2):403. doi: 10.1007/s10557-020-07029-2

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction (Cardiovascular Drugs and Therapy, (2020), 10.1007/s10557-020-06999-7)

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this